Have to agree with you. The new investor has put up 12 million after a NDA. No way is anyone going to put up that kind of money without proof in the pudding. IMHO
One possibility of the peer reviewed article which I hadn't considered before might be to make 'publc' Dcvaxl's efficacy, and force the FDA's hand, so to speak, if they are in bed with BP (as many on this board have intimated) and are looking for a reason to deny the phase lll... if so many surgeons are lauding Dcvaxl then they can't just deny the phase lll and sweep it under the rug...